Psoralen plus ultraviolet A does not increase the risk of cataracts: a 25-year prospective study

Full Article

Malanos D Stern R

J Am Acad Dermatol. 2007;57(2):231-7. doi:10.1016/j.jaad.2007.04.027

A common fear associated with the use of psoralen plus ultraviolet A (PUVA) therapy is the increased risk of unwanted side effects, for example cataracts. A study conducted by Malanos and Stern evaluated the aforementioned risk with promising results. Based on the cohort studied and the data collected from a 24 year time span, it was determined that “increasing exposure to PUVA does not increase cataract risk among persons using eye protection.”